In HepG2 cells, HCC-2 and HCC-3 primary cancer cells, stable expression of the HBO1-expressing GV369 construct (“HBO1-OE”) resulted in significant upregulation of HBO1 mRNA (Fig. 5G). The gene discussed is KAT7; the disease is cancer.